IL‐1 plays a vital role in the pathophysiology of multiple sclerosis (MS), and inhibition of IL‐1 signaling in the BBB markedly ameliorates the severity of MS by downregulating the expression of ICAM‐1 and other proinflammatory mediators.20 The gene discussed is ICAM1; the disease is myeloid sarcoma.